Multiple Sclerosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
GlobalData estimates that the global Multiple Sclerosis (MS) therapeutics market was valued at $9,237m in 2011. The global MS therapeutics, which includes Disease Modifying Drugs (DMDs) and drugs for symptom management, is forecast to grow at a Compound Annual Growth Rate (CAGR) of 3.2% over the next eight years, to reach $11,914m by 2019. The rapid growth of the market during 2006-2011 (13.6% CAGR) was mainly due to the growth in diagnosed and treated patients. The treated patient pool registered...
View full press release